D-Wave and Japan Tobacco Validate Quantum and AI Workflow Towards Generative Drug Discovery

Insider Brief:

• D-Wave and Japan Tobacco’s pharma division completed a proof-of-concept project using a quantum-hybrid workflow to enhance LLMs for generative drug discovery.

• The integration of D-Wave’s annealing quantum computing with JT’s AI models led to the generation of more valid, “drug-like” molecules compared to classical methods.

• Molecules produced through QPU-assisted training showed higher drug-likeness scores and better energy efficiency,…